Haier Named Official Partner of the Australian Open for 2025-2027

Haier Named Official Partner of the Australian Open for 2025-2027

MELBOURNE, Australia, Nov. 25, 2024 /PRNewswire/ -- Haier announced today it is the official TV and Appliance partner of the Australian Open and Summer of Tennis events. The two sides marked the partnership with an announcement ceremony in...

Scienjoy Holding Corporation Reports Nine Months ended September 30, 2024 Unaudited Financial Results

Scienjoy Holding Corporation Reports Nine Months ended September 30, 2024 Unaudited Financial Results

Income from Operations up 313.7% Year Over Year Net Income Increased by Approximately US$10 million Year Over Year BEIJING, Nov. 25, 2024 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive...

Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024

Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024

BEIJING, Nov. 25, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2024. Highlights for the Quarter...

Legacy Meets Mindful Luxury at Hakone Sanctuary: Embrace Nature's Finest at Kinnotake Resorts with Black Friday Exclusive

Legacy Meets Mindful Luxury at Hakone Sanctuary: Embrace Nature's Finest at Kinnotake Resorts with Black Friday Exclusive

HAKONE, Japan, Nov. 25, 2024 /PRNewswire/ -- Kinnotake Corporation has announced a Black Friday Sale for Kinnotake Resorts, granting exclusive access to three exceptional properties in Hakone, Kanagawa Prefecture. Each resort offers a distinctive...

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

ROCKVILLE, Md. and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...

SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024

SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024

SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its...

Corinex Ranked Number 331 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Corinex Ranked Number 331 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Attributes 352% Revenue Growth to expanded product offerings, successful strategic partnerships, and increased demand for grid flexibility solutions in international markets VANCOUVER, BC, Nov. 22, 2024 /PRNewswire/ -- Corinex today announced it...

At Its European Innovation Day 2024, Huawei Advocates Collaboration to Unlock Europe's Potential

At Its European Innovation Day 2024, Huawei Advocates Collaboration to Unlock Europe's Potential

PARIS, Nov. 22, 2024 /PRNewswire/ -- Huawei hosted the 2024 "Europe Innovation Day" in Paris, an event where European tech leaders, business representatives, and innovation experts explored opportunities for cross-border and cross-industry...

Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA

Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA

HONG KONG, Nov. 22, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted its supplemental new drug application (sNDA) for penpulimab, a...

Qudian Inc. Reports Third Quarter 2024 Unaudited Financial Results

Qudian Inc. Reports Third Quarter 2024 Unaudited Financial Results

XIAMEN, China, Nov. 22, 2024 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced its unaudited financial results for the quarter ended September 30, 2024. Third...

  • 1
  • ...
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • menu
    menu